Printer Friendly

Browse Metastasis topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Anupam Kher calls Sonali Bendre a hero. Aug 12, 2018 182
Bad cholesterol helps cancer spread: Study. Aug 9, 2018 230
Germany : How cancer cells hibernate. Aug 9, 2018 465
Lipomet: Dietary influences on metastasis: How, When, And why. Aug 7, 2018 373
Rapper C Struggs dead at 32 after cancer 'rips through his body' in days; The Dallas-based rapper has died after doctors gave him just eight weeks to live. Aug 4, 2018 570
Sonali Bendre is stable, says husband Goldie Behl. Aug 3, 2018 159
Sonali Bendre a fighter, says Omung Kumar. Aug 1, 2018 262
FDA Grants Breakthrough Therapy Designation for Lenvima/Keytruda Combination as Therapy for Previously Treated Patients with Advanced and/or Metastatic non-MSI-H/pMMR Endometrial Carcinoma. Aug 1, 2018 756
Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Announce U.S. FDA Grants Breakthrough Therapy Designation for LENVIMA. Jul 31, 2018 1616
Diagnostic accuracy of glypican-3 in differentiating hepatocellular carcinoma from metastatic liver tumours. Jul 25, 2018 1337
Clinicopathological prognostic factors of oral squamous cell carcinoma: An experience of a tertiary care hospital. Report Jul 25, 2018 2869
Calcified dural based meningioma, mimicker of metastasis on skeletal scintigraphy. Jul 25, 2018 422
Detection of sputum cofilin-1 as indicator of malignancy. Rangel, M.P.; Antonangelo, L.; Acencio, M.M.P.; Faria, C.S.; de Sa, V.K.; Leao, P.S.; Farhat, C.; Fa Jul 25, 2018 3422
US FDA accepts Immunomedics' biologics license application for sacituzumab govitecan. Jul 20, 2018 140
US FDA accepts Immunomedics' biologics license application for sacituzumab govitecan. Jul 20, 2018 136
United States : FDA grants Breakthrough Therapy Designation for Roches Tecentriq in combination with Avastin as first-line treatment for advanced or metastatic hepatocellular carcinoma (HCC). Jul 18, 2018 437
United States : FDA Grants Breakthrough Therapy Designation for Genentechs TECENTRIQ in Combination With Avastin as First-Line Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC). Jul 18, 2018 492
United States : Anti-PD-L1 Immunotherapy Plus ABRAXANE Significantly Reduced the Risk of Disease Worsening or Death in Patients with Metastatic or Locally Advanced Triple Negative Breast Cancer in Phase III IMpassion130 Study. Jul 13, 2018 282
United States : Seattle Genetics Announces Publication of Results from Two Tucatinib Phase 1b Clinical Trials in HER2-Positive Metastatic Breast Cancer. Financial report Jul 13, 2018 873
United States : Seattle Genetics and Astellas Announce Progress in Enfortumab Vedotin Urothelial Cancer Clinical Development Program. Jul 13, 2018 388
Pfizer reports FDA approves sNDA to broaden XTANDI indication. Jul 13, 2018 110
Bavarian Nordic doses first patient in phase 2 trial of combination therapy of cancer vaccine CV301 and Nivolumab in metastatic colorectal cancer. Jul 12, 2018 315
Bavarian Nordic doses first patient in phase 2 trial of combination therapy of cancer vaccine CV301 and Nivolumab in metastatic colorectal cancer. Jul 12, 2018 310
Bavarian Nordic doses first patient in phase 2 trial of combination therapy of cancer vaccine CV301 and Nivolumab in metastatic colorectal cancer. Jul 12, 2018 314
Sonali Bendre weeps as her long hair gets cut off ahead of cancer treatment; The actress revealed she was trying to remain positive after being diagnosed with metastatic cancer this month. Jul 11, 2018 372
Bristol-Myers' Opdivo approved for MSI-H/dMMR metastatic colorectal cancer. Jul 11, 2018 267
Seattle Genetics announces results of two Phase 1b trials. Financial report Jul 11, 2018 319
VBL says data shows MOSPD2 can play major role in breast cancer cell migration. Jul 10, 2018 190
Canada : Phase III IMpassion130 Study Showed Genentech's TECENTRIQ Plus Abraxane Significantly Reduced the Risk of Disease Worsening or Death in People With Metastatic or Locally Advanced Triple Negative Breast Cancer. Jul 9, 2018 257
Metastasis: Understanding high-grade cancer. Jul 6, 2018 597
United States : LYNPARZA (olaparib) Approved in Japan for BRCA-Mutated Metastatic Breast Cancer. Jul 6, 2018 371
United States : FDA Grants Priority Review to Mercks Supplemental Biologics License Application for KEYTRUDA (pembrolizumab) in Combination with Chemotherapy as First-Line Treatment for Metastatic Squamous Non-Small Cell Lung Cancer. Jul 6, 2018 265
US FDA Approval Granted to Combination Braftovi with Mektovi for Metastatic Melanoma. Jul 2, 2018 194
Novartis Funds Metastatic Breast Cancer Advocacy Groups through STEP Program. Jul 2, 2018 191
Halo Publishing International, Inc. Publishes "Handle With Love: One Woman's Approach to Kicking a Nasty Cancer". Jul 2, 2018 511
LYNPARZA approved in Japan for BRCA-mutated metastatic breast cancer. Jul 2, 2018 200
A Multi-Pronged Attack Against Prostate Cancer. Jul 1, 2018 1202
Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth. Johnson, Daniel N.; Furtado, Larissa V.; Long, Bradley C.; Zhen, Chao Jie; Wurst, Michelle; Mujacic, Jul 1, 2018 9299
Performance Characteristics of Cerebrospinal Fluid Cytology: An Analysis of Responses From the College of American Pathologists Nongynecologic Cytopathology Education Program. Tabatabai, Z. Laura; Auger, Manon; Souers, Rhona J.; Teot, Lisa; Davey, Diane D. Jul 1, 2018 3417
Array BioPharma wins US FDA approval for BRAFTOVI & MEKTOVI combination for treating metastatic melanoma. Jun 28, 2018 266
Presbyterian/St. Luke's Medical Center Performs Cutting Edge Minimally Invasive Bone Cancer Surgery. Jun 28, 2018 589
Lonsurf Trial Shows Improved Overall Survival in Patients with Metastatic Gastric Cancer. Clinical report Jun 27, 2018 251
MetaStat Preclinical Studies Demonstrate Benefit of MENA-pathway Inhibition in Aggressive Cancer. Jun 26, 2018 218
A 20 YEARS' EXPERIENCE ON GRANULOSA CELL TUMOUR. Martin, P. Jovita M.; Kalaichelvi, K.; Lakshminarasimhan; Ramkumar; Dheenadhayalan Report Jun 25, 2018 4199
Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. Yokom, Daniel W.; Stewart, John; Alimohamed, Nimira S.; Winquist, Eric; Berry, Scott; Hubay, Stacey; Report Jun 24, 2018 6007
Putting the Brakes on Metastatic Cancer. Jun 23, 2018 624
United States : Published Case Report Demonstrates the Clinical Utility of Biocept's CTC Platform in the Management of Patients with Metastatic Breast Cancer. Jun 22, 2018 396
MetaStat presents results from MAPKAPK2 treatment studies at AACR. Jun 21, 2018 143
Positivity Can Save Your Life, Woman Proves by Overcoming Battle against Rare Cancer. Jun 20, 2018 508
Positivity Can Save Your Life, Woman Proves by Overcoming Battle against Rare Cancer. Jun 20, 2018 508
Brain tumors. Jun 18, 2018 558
United States : Seattle Genetics Announces First Patient Dosed in Phase 2 Trial of Tisotumab Vedotin for Women with Recurrent or Metastatic Cervical Cancer. Jun 18, 2018 445
United States : Advaxis Announces Dosing Of First Patient With ADXS-NEO, An Investigational Customized Immunotherapy Approach Targeting Personal Neoantigens. Jun 18, 2018 372
United States : Mercks KEYTRUDA (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival in First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in Phase 3 KEYNOTE-407 Study. Report Jun 13, 2018 280
United States : KEYTRUDA (pembrolizumab) Monotherapy Significantly Improved Overall Survival in KEYNOTE-042 Study as First-Line Treatment for Locally Advanced or Metastatic NSCLC Patients Whose Tumors Expressed PD-L1 (TPS ?1%). Report Jun 13, 2018 415
United States : LYNPARZA (olaparib) in Combination with Abiraterone Delayed Disease Progression in Metastatic Castration-Resistant Prostate Cancer. Clinical report Jun 13, 2018 565
United States : FDA Approves Mercks KEYTRUDA (pembrolizumab) for Previously Treated Patients with Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 (CPS Greater Than or Equal to 1). Jun 13, 2018 811
Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation Given Priority Review Status with FDA. Jun 12, 2018 277
Tyme Technologies released detailed data from FHS and SM-88 programs. Jun 12, 2018 196
Advaxis announces dosing in first patient with ADXS-NEO. Jun 11, 2018 232
United States : Erdafitinib Phase 2 Study Results Show Promise in the Treatment of Metastatic Urothelial Cancer. Jun 11, 2018 480
Japan,United States : Seattle Genetics and Astellas Present at ASCO 2018 on Enfortumab Vedotin in Patients with Locally Advanced or Metastatic Urothelial Cancer Previously Treated with Checkpoint Inhibitor Therapy. Jun 11, 2018 340
Oncotheranostics: Advanced theranostic nanomedicines for oncology. Development of new combinatorial therapies for primary and metastatic breast cancer. Jun 9, 2018 357
United States : FDA Expands Lilly's ALIMTA (pemetrexed) Label to Include Combination with KEYTRUDA (pembrolizumab) and Carboplatin as First-Line Treatment for Metastatic Nonsquamous Non-Small Cell Lung Cancer, Irrespective of PD-L1 Expression. Jun 9, 2018 546
United States : Preliminary Data for NKTR-214 in Combination with Opdivo (nivolumab) for Patients with Stage IV Metastatic Melanoma, Renal Cell Carcinoma, and Urothelial Cancers Presented at ASCO 2018. Jun 9, 2018 460
Metastatic Urothelial Cancer Drug Erdafitinib Yields Positive Results in Phase 2 Study. Clinical report Jun 8, 2018 271
It matters how you target cancer. Jun 7, 2018 525
KEYNOTE-042 Phase 3 Study of Keytruda as First-Line Treatment for Locally Advanced or Metastatic NSCLC Patients Whose Tumors Expressed PD-L1 Yields Positive Results. Report Jun 7, 2018 344
Puma biotechnology Releases Interim Results of Phase Ib/II Trial of PB272 in Combination with TDM-1 in HER2-Positive Metastatic Breast Cancer. Jun 7, 2018 282
Phase 3 KEYNOTE-407 Study of Keytruda Plus Chemotherapy Shows Increased Overall Survival in First-Line Treatment of Metastatic Squamous NSCLC. Report Jun 7, 2018 325
Oral Chemotherapy Tesetaxel Shows a 45% Confirmed Response Rate in Patients with HER2 Negative, HR Positive, Metastatic Breast Cancer. Jun 7, 2018 257
Immunomedics to present business update at ASCO. Jun 4, 2018 118
Usefulness of [.sup.18]F-FDG PET/CT in Cutaneous Melanoma Patients with Negative Sentinel Lymph Nodes and High Clark Levels: Sentinel Lenf Nodu Negatif Yuksek Clark Seviyeli Kutanoz Melanom Hastalarinda [.sup.18]F-FDG PET/BT'nin Degeri. Topuz, Ozge Vural; Gortan, Fatma Arzu; Doner, Zubeyde Rana Kaya; Onsel, Cetin; Sayman, Haluk Burcak Report Jun 1, 2018 3689
Disseminated Multi-system Sarcoidosis Mimicking Metastases on [.sup.18]F-FDG PET/CT: [.sup.18]F-FDG PET/BT'de Metastazi Taklit Eden Dissemine Multisistem Sarkoidoz. Makis, William; Palayew, Mark; Rush, Christopher; Probst, Stephan Case study Jun 1, 2018 547
Reversibility and safety of KISS1 metastasis suppressor gene vaccine in immunocastration of ram lambs. Han, Yan-Guo; Liu, Gui-Qiong; Jiang, Xun-Ping; Xiang, Xing-Long; Huang, Yong- Fu; Nie, Bin; Zhao, Ji Report Jun 1, 2018 4169
T-cell Thymic Lymphoma With Proventricular Metastasis in a Florida Scrub Jay (Aphelocoma coerulescens). Kruse, Tamara; Zachariah, Trevor; McManamon, Rita Report Jun 1, 2018 2716
Expression of EpCAM protein in gastric cancer cells may contribute to its histogenesis. Niziol, M.; Kuczynska, P.; Misiura, M.; Zinczuk, J.; Zareba, K.; Ustymowicz, W.; Cwiklinska-Dworakow Report Jun 1, 2018 2950
Left-Sided Colonic Obstruction Due to Brid Ileus and Coexisting Right Colon Cancer without Palpable Mass/Sol Kolon Kaynakli Brid Ileus ile Seyreden Ele Gelmeyen Sag Kolon Kanseri. Beksac, Kemal; Ustuner, Mehmet Akif; Cetin, Bahadir Case study Jun 1, 2018 1509
Pfizer's Xalkori receives FDA breakthrough therapy designation in 2 indications. May 29, 2018 152
Researchers at Cancer Treatment Centers of America' in Suburban Chicago Evaluating Investigational Medication for HER2-Positive Breast Cancer. Clinical report May 24, 2018 754
BBC presenter Rachael Bland reveals devastating 'incurable' cancer diagnosis and how trial drugs have 'turned her into a lab rat'; The You, Me and the Big C podcast co-host revealed she is taking a new trial drug after being told her cancer was metastatic. May 22, 2018 451
Immunomedics files BLA for treatment of metastatic triple-negative breast cancer. May 21, 2018 202
Immunomedics files BLA for treatment of metastatic triple-negative breast cancer. May 21, 2018 198
EVALUATION OF TRIPLE ASSESSMENT FOR DIAGNOSIS OF BREAST CANCER IN A TERTIARY CENTRE. Goel, Kanwar Singh; Goel, Sapna Report May 21, 2018 3593
Switzerland : Phase III IMpower150 study showed Roches Tecentriq and Avastin plus carboplatin and paclitaxel helped people with a specific type of metastatic lung cancer live significantly longer compared to Avastin plus carboplatin and paclitaxel. May 18, 2018 480
Switzerland : Follow-up phase III data showed Roches Alecensa helped people with ALK-positive metastatic non-small cell lung cancer live a median of almost three years without their disease worsening or death. May 18, 2018 413
Lonsurf (trifluridine/tipiracil) Plus Supportive Care Improves Overall Survival in Patients with Metastatic Gastric Cancer. May 14, 2018 306
PREVALENCE OF INTRAORBITAL NEOPLASMS- A RETROSPECTIVE STUDY FOR SEVEN YEARS. Seena, A.R.; Sreedevi, A.R. Report May 14, 2018 2316
Switzerland : Roche provides update on Phase III study of Tecentriq (atezolizumab) and Cotellic (cobimetinib) in people with heavily pre-treated locally advanced or metastatic colorectal cancer. May 12, 2018 305
Lonsurf (trifluridine/tipiracil) Plus Supportive Care Improves Overall Survival in Patients with Metastatic Gastric Cancer. May 11, 2018 306
Oncolytics and FDA agree plan for phase 3 trial of metastatic breast cancer treatment. May 10, 2018 187
Oncolytics and FDA agree plan for phase 3 trial of metastatic breast cancer treatment. May 10, 2018 183
Parenting concerns affect mothers with cancer:Study. May 9, 2018 319
Debiopharm International SA passes US FDA Fast Track designation for Debio 1347 for treating metastatic tumours. May 9, 2018 207
Taiho Oncology collects encouraging topline data from pivotal Phase 3 trial of LONSURF in metastatic gastric cancer. May 9, 2018 263
Debiopharm International SA passes US FDA Fast Track designation for Debio 1347 for treating metastatic tumours. May 9, 2018 203
Taiho Oncology collects encouraging topline data from pivotal Phase 3 trial of LONSURF in metastatic gastric cancer. May 9, 2018 259
Role of Recursive Partitioning Analysis and Graded Prognostic Assessment on Identifying Non-Small Cell Lung Cancer Patients with Brain Metastases Who May Benefit from Postradiation Systemic Therapy. Liu, Shuai; Chen, Peng; Liu, Yan-Wei; Gu, Xue-Nan; Qiu, Xiao-Guang; Li, Bo Report May 9, 2018 4742
Roche's cancer immunotherapy TECENTRIQ (atezolizumab) granted FDA priority review for initial treatment of specific type of metastatic lung cancer. May 8, 2018 255
Roche's cancer immunotherapy TECENTRIQ (atezolizumab) granted FDA priority review for initial treatment of specific type of metastatic lung cancer. May 8, 2018 251
Switzerland : FDA grants priority review to Roches cancer immunotherapy TECENTRIQ (atezolizumab) for initial treatment of people with a specific type of metastatic lung cancer. May 8, 2018 275
Is protein responsible for breast cancer? May 7, 2018 395
IN VIVO PROTON MR SPECTROSCOPY IN DIAGNOSIS OF INTRACRANIAL CYSTIC LESIONS. Ramasamy, Sukumar; Alagappan, Periakaruppan; Chellathurai, Amarnath; Muthaiyan, Priya; Rajan, Suja Report May 7, 2018 3568
Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers. Clinical report May 4, 2018 1254
Taiwanese scientists isolate gene that spurs spread of cancer. May 3, 2018 395
The role of neutrophil-lymphocyte ratio as a prognostic indicator in patients undergoing nephrectomy for renal cell carcinoma. Grimes, Nathan; Hannan, Cathal; Tyson, Matthew; Thwaini, Ali Brief article May 2, 2018 2533
Inaugural Chicago Metsquerade on May 11 - A Fundraiser for Stage IV Breast Cancer Research. May 1, 2018 553
Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists. Lewis, James S., Jr.; Beadle, Beth; Bishop, Justin A.; Chernock, Rebecca D.; Colasacco, Carol; Lacch Report May 1, 2018 31769
Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist. Nicholson, Andrew G.; Tsao, Ming S.; Travis, William D.; Patil, Deepa T.; Galateau-Salle, Francoise; Brief article May 1, 2018 13658
A Preliminary Study on the Estimation of the Number of Cancer Patients Eligible for Hadron Therapy in Iran and Fars Province. Hosseini, Mohammad Amin; Mohamadianpanah, Mohammad; Zare-Bandeamiri, Mohammad; Mosleh-Shirazi, Moham Report May 1, 2018 3067
Evaluating the role for renal biopsy in T1 and T2 renal masses: A single-centre study. Hoare, Dylan; Evans, Howard; Richards, Heidi; Samji, Rahim Report Apr 28, 2018 3558
Replacement Planting In The Metastases-riem, Landscaping Works. Apr 27, 2018 126
LIVE FOR TODAY; Running with terminal cancer by Kevin Webber. Apr 22, 2018 334
United Kingdom : Updated overall survival data for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer presented at AACR. Apr 21, 2018 363
amcure Pre-Clinical Data on AMC303's Anti-tumor and Anti-Metastatic Effects Presented at AACR. Apr 20, 2018 280
AstraZeneca says FDA approves Tagrisso as 1st-line treatment for certain cancers. Apr 19, 2018 106
Zulekha uses new technique for cancer treatment. Apr 19, 2018 418
Roche wins US FDA approval for Premarket Approval (PMA) supplement for the cobas EGFR Mutation Test v2 for treating metastatic NSCLC. Apr 19, 2018 360
Roche wins US FDA approval for Premarket Approval (PMA) supplement for the cobas EGFR Mutation Test v2 for treating metastatic NSCLC. Apr 19, 2018 364
AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING pathway. Apr 18, 2018 1401
ROLE OF ADDITION OF NON-CONTRAST MRI SCAN BRAIN WITH SPECIFIC SEQUENCES (GRE, SWI, TOF ANGIOGRAM & TOF VENOGRAM SEQUENCES) TO ROUTINE NON-CONTRAST CT SCAN BRAIN AT INITIAL EMERGENCY WORK UP IN EVALUATION OF INTRA CEREBRAL HAEMORRHAGE. R, Somasekhar; Elaprolu, Praveen Apr 16, 2018 1552
DNA Methylation and Uveal Melanoma. Yang, Zhi-Kun; Yang, Jing-Yun; Xu, Zhuo-Zai; Yu, Wei-Hong Report Apr 15, 2018 4732
The University of Texas MD Anderson Cancer Center and Nanobiotix have an Agreement to Run Immunotherapeutic Pre-clinical Research in Lung Cancer Combining NBTXR3 and Nivolumab. Apr 11, 2018 1280
FINE NEEDLE ASPIRATION CYTOLOGY OF LYMPH NODES WITH HISTOLOGICAL CORRELATION--A STUDY OF 1033 CONSECUTIVE CASES, A SOUTH INDIAN STUDY. Gudibande, Tejaswini; Udupa K., Aniruddha; Puranik B., Rekha Report Apr 9, 2018 3842
EMA Accepts Regulatory Submission for Lynparza (olaparib) in BRCA-Mutated HER2-Negative Metastatic Breast Cancer. Apr 6, 2018 399
William Blair downgrades Incyte after metastatic melanoma study failure. Apr 6, 2018 152
The true malignancy risk of Bosniak III cystic renal lesions: Active surveillance or surgical resection? Lam, Cameron Jonathan; Kapoor, Anil Report Apr 6, 2018 2709
Kidney Cancer Research Network of Canada (KCRNC) consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials. Karakiewicz, Pierre I.; Zaffuto, Emanuele; Kapoor, Anil; Basappa, Naveen S.; Bjarnason, Georg A.; Bl Report Apr 6, 2018 4565
Nerlynx (neratinib) in Combination With Capecitabine or Paclitaxel Included in NCCN Guidelines as Treatment Option for Patients With Breast Cancer Brain Metastases. Apr 5, 2018 183
Singapore : Calix Senior Director Bernd Hesse Elected to Broadband Forum Board of Directors. Apr 4, 2018 668
United States : The European Medicines Agency accepts regulatory submission for Lynparza in BRCA-mutated HER2-negative metastatic breast cancer. Apr 4, 2018 255
Medicare Issues Local Draft Coverage Supporting Use of Cell-based Liquid Biopsy Test in Patients with Metastatic CRPC. Apr 3, 2018 313
Singapore : NUS scientists develop novel patient cancer cell culture test kit for personalised, precise cancer therapy. Apr 3, 2018 668
Esthesioneuroblastoma with widespread distant metastasis: Case report and literature review. Khosla, Manraj; Pecci, Cristina; Do, Annie; McGhan, Lee; Seetharam, Mahesh; Sue, Richard Case study Apr 1, 2018 108
Risky Alternatives. Brief article Apr 1, 2018 143
Validation of predictors for lymph node status in penile cancer: Results from a population-based cohort. Qu, X. Melody; Siemens, D. Robert; Louie, Alexander V.; Yip, Darwin; Mahmud, Aamer Report Apr 1, 2018 4926
Calcium Mobilization and Inhibition of Akt Reduced the Binding of PEO-1 Cells to Fibronectin/[Ca.sup.2+] Mobilizasyonu ve Akt Inhibisyonu ile PEO-1 Hucrelerinin Fibronektine Baglanmasinda Azalma. Kilicaslan, Seda Mehtap Sari; Ayrim, Aysun; Apaydin, Elif; Incesu, Zemin Report Apr 1, 2018 4503
Bristol-Myers Squibb Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for Certain Metastatic Colorectal Cancer Patients Accepted by US FDA for Priority Review. Mar 29, 2018 280
FDA Grants Breakthrough Therapy Designation to Seattle Genetics and Astellas for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer. Mar 28, 2018 320
United States : U.S. Food and Drug Administration (FDA) Accepts Bristol-Myers Squibbs Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for Previously Treated Patients with MSI-H or dMMR Metastatic Colorectal Cancer for Priority Review. Mar 28, 2018 296
United States : Seattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer. Mar 28, 2018 380
A CLINICO-PATHOLOGICAL STUDY OF SQUAMOUS CELL CARCINOMA OF GINGIVOBUCCAL COMPLEX IN PUNJAB. Pervej, Khurshid; Singh, Manjit; Singh, Baldev; Kundai, Ramesh Kumar; Singh, Anmol Report Mar 26, 2018 3334
Pfizer and Astellas Pharma submit supplemental New Drug Application to US FDA for Xtandi. Mar 21, 2018 229
Pfizer and Astellas Pharma submit supplemental New Drug Application to US FDA for Xtandi. Mar 21, 2018 225
Pfizer, Astellas Seek to Expand Indication of Xtandi to include Men with Non-metastatic CRPC. Mar 21, 2018 304
Astex Collaborator Janssen Receives US FDA Breakthrough Therapy Designation for Erdafitinib for Metastatic Urothelial Cancer. Mar 20, 2018 235
Astellas announces US FDA priority review for XTANDI (enzalutamide) sNDA for non-metastatic castration-resistant prostate cancer. Mar 20, 2018 254
Astellas announces US FDA priority review for XTANDI (enzalutamide) sNDA for non-metastatic castration-resistant prostate cancer. Mar 20, 2018 258
United States : U.S. FDA Grants Priority Review for a Supplemental New Drug Application (sNDA) for XTANDI (enzalutamide) in Non-Metastatic Castration-Resistant Prostate Cancer (CRPC). Mar 20, 2018 456
Primary Pulmonary Germ Cell Tumor with Bone Metastasis. Li, Tong-Tong; Yan, Xu; Zhou, Tong; Liu, Ying; Yu, Zhen-Xiang Clinical report Mar 18, 2018 1175
Pulmonary Metastasis of a Gigantic Cystosarcoma Phyllodes of the Breast. Gao, Yan-Hong; Xiang, Hui-Juan; Zhu, Jian; Duan, Yun; Zhou, Pei Clinical report Mar 18, 2018 771
Janssen wins US FDA's breakthrough therapy designation for erdafitinib for metastatic urothelial cancer. Mar 16, 2018 253
Janssen wins US FDA's breakthrough therapy designation for erdafitinib for metastatic urothelial cancer. Mar 16, 2018 249
United States : Janssen Announces U.S. FDA Breakthrough Therapy Designation for Erdafitinib in the Treatment of Metastatic Urothelial Cancer. Mar 16, 2018 259
IO Biotech and MSD Partner to Evaluate IO102 in combination with Keytruda (pembrolizumab) in Patients with Metastatic NSCLC. Mar 14, 2018 265
United States : Seattle Genetics Completes Acquisition of Cascadian Therapeutics. Mar 14, 2018 403
Bavarian Nordic to commence phase 2 trial investigating combination of its CV301 and Bristol-Myers Squibb's nivolumab in metastatic colorectal cancer. Mar 9, 2018 294
Bavarian Nordic to commence phase 2 trial investigating combination of its CV301 and Bristol-Myers Squibb's nivolumab in metastatic colorectal cancer. Mar 9, 2018 295
Bavarian Nordic to commence phase 2 trial investigating combination of its CV301 and Bristol-Myers Squibb's nivolumab in metastatic colorectal cancer. Mar 9, 2018 290
Seattle Genetics completes Cascadian acquisition, getsTucatinib rights. Mar 9, 2018 288
Sorrento Therapeutics says CAR-T cell therapy demonstrates therapeutic activity. Mar 5, 2018 387
DISTAL PANCREATECTOMY IN THE SURGICAL TREATMENT OF PANCREATIC CANCER--A STUDY. Choudhury, Purujit Report Mar 5, 2018 2868
STEREOLOGICAL ANALYSIS OF ANDROGEN RECEPTORS IN PROSTATE CANCER AND BENIGN PROSTATIC HYPERPLASIA/STEREOLOSKA ANALIZA ANDROGENIH RECEPTORA KOD KARCINOMA I BENIGNE HIPERPLAZIJE PROSTATE. Dajko, Sandra Trivunic; Bogdanovic, Jovo; Vojinov, Sasa; Visnjic, Bojana Andrejic Report Mar 1, 2018 4075
Neoadjuvant data promising, role unclear. Mar 1, 2018 313
Extraskeletal Myxoid Chondrosarcoma of Nasopharynx: An Oncologic Entity Rarely Reported. Purkayastha, Abhishek; Sharma, Neelam; Dutta, Vibha Report Mar 1, 2018 1557
Genomic Health Launches Liquid Biopsy Test to Predict Treatment Response in Metastatic Castration-resistant Prostate Cancer. Mar 1, 2018 285
First Patient Dosed in Merrimack Phase 2 Clinical Study of MM-121 in Patients with Post-Menopausal Metastatic Breast Cancer. Clinical report Mar 1, 2018 257
Metastatic adenocarcinoma involving atypical meningioma. Agostini-Vulaj, Diana; Rosella, Peter; Yeaney, Gabrielle Case study Mar 1, 2018 1143
Sustained Ventricular Tachycardia Secondary to Cardiac Metastasis of Lung Cancer. Li, Ying-Ying; Wang, Hua; Cui, Ya-Dong; Liu, Hang-Yu; Yang, Jie-Fu Case study Mar 1, 2018 1192
MetaStat announces completion of pilot research project with Celgene. Feb 28, 2018 187
Appendiceal and rectal carcinomas with Krukenberg tumour mimicking primary ovarian cancer. Feb 28, 2018 1558
Eli Lilly receives additional FDA approval for Verzenio. Feb 26, 2018 139
United States : ERLEADA (apalutamide), the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer, available for order at Biologics, Inc. Feb 22, 2018 362
United States : Advaxis Submits Conditional Marketing Authorization Application For Axalimogene Filolisbac For The Second-Line Treatment Of Metastatic Cervical Cancer In European Union. Feb 19, 2018 500
STUDY OF HISTOMORPHOLOGY AND IMMUNOHISTOCHEMICAL ANALYSIS IN BREAST NEOPLASM. Kaushal, Manish; Shukla, Arvind; Patil, Pankaj Report Feb 19, 2018 2246
Results of Phase II Trial of Durvalumab in Recurrent or Metastatic Head and Neck Cancer with Low or Negative Expression of PD-L1 Protein Presented at 2018 Multidisciplinary Head and Neck Cancers Symposium. Feb 16, 2018 308
The Janssen Pharmaceutical Companies wins the US FDA's approval for ERLEADA for non-metastatic castration-resistant prostate cancer. Feb 15, 2018 304
The Janssen Pharmaceutical Companies wins the US FDA's approval for ERLEADA for non-metastatic castration-resistant prostate cancer. Feb 15, 2018 300
Janssen Files MAA for Apalutamide for Treatment of High-Risk Non-Metastatic CRPC in Europe. Feb 14, 2018 282
United States : Apalutamide helps delay spread of several prostate cancers in phase 3 clinical trial. Feb 13, 2018 306
Combatcancer: Rational combination therapies for metastatic cancer. Feb 12, 2018 372
DIFFERENTIATION BETWEEN BENIGN AND MALIGNANT THYROID NODULE WITH DIFFUSION WEIGHTED MAGNETIC RESONANCE IMAGING AND APPARENT DIFFUSION COEFFICIENT MEASUREMENTS AND ITS HISTOPATHOLOGICAL CORRELATION. M., Noufal P.; Ramakrishnan, K.G.; Kurup, Shailage; Ali, Naseer; Janardhanan, Sujith; Rabia, Tejmal Report Feb 12, 2018 5590
Xtandi Plus ADT Reduces Risk of Metastasis, Death, PSA Progression in Men with CRPC Compared to ADT Alone. Feb 9, 2018 420
United States : ZYTIGA (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer. Feb 9, 2018 543
United States : ERLEADA (apalutamide), a Next-Generation Androgen Receptor Inhibitor, Lowered Risk of Metastasis or Death in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. Feb 9, 2018 297
Germany : Bayer to showcase latest prostate cancer research at ASCO GU 2018 Cancer Symposium. Feb 8, 2018 479
Japan : Daiichi Sankyo Initiates Phase 1 Study of U3-1402 in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer. Feb 8, 2018 352
ANGLE plc and Abbott Laboratories to collaborate on metastatic breast cancer study. Feb 6, 2018 215
ANGLE plc and Abbott Laboratories to collaborate on metastatic breast cancer study. Feb 6, 2018 211
Astellas Pharma, Pfizer announce results from Phase 3 PROSPER trial. Feb 5, 2018 164
USPTO Grants Skin Biology Patent for Non-toxic Skin Cancer Therapy with Copper Peptides. Feb 2, 2018 152
FDA GRANTS FAST TRACK DESIGNATION TO ANTI-HER2. Feb 1, 2018 878
Colorectal cancer in South Africa: An assessment of disease presentation, treatment pathways and 5-year survival. Brand, M.; Gaylard, P.; Ramos, J. Report Feb 1, 2018 3512
Radiotherapy for Gastrointestinal Stromal Tumors. Ozkan, Emine Report Feb 1, 2018 6095
Testosterone suppression in the treatment of recurrent or metastatic prostate cancer--A Canadian consensus statement. Klotz, Laurence; Shayegan, Bobby; Guillemette, Chantal; Collins, Loretta L.; Gotto, Geoffrey; Gueret Report Feb 1, 2018 6012
Supplementary data: Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statement. Klotz, Laurence; Shayegan, Bobby; Guillemette, Chantal; Collins, Loretta L.; Gotto, Geoffrey; Gueret Feb 1, 2018 1364
A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. Khalaf, Daniel Joseph; Aviles, Claudia M.; Azad, Arun A.; Sunderland, Katherine; Todenhofer, Tilman; Report Feb 1, 2018 4584
Association between life events after diagnosis of breast cancer and metastasis. Dourado, Claudia de Souza; de Souza, Camila Brandao; de Castro, Denise Silveira; Zandonade, Eliana; Feb 1, 2018 5435
Alligator Bioscience selects Theradex Oncology as CRO for planned phase I study of ATOR-1015. Jan 29, 2018 131
Alligator Bioscience selects Theradex Oncology as CRO for planned phase I study of ATOR-1015. Jan 29, 2018 127
FDA Grants Synthon Fast Track Designation for Anti-HER2 ADC for Pre-treated HER2-positive Metastatic Breast Cancer. Jan 29, 2018 208
Clinical Data from Taiho Oncology and Servier Study of Lonsurf (trifluridine and tipiracil) in Metastatic Colorectal Cancer Presented at ASCO 2018 Gastrointestinal Cancers Symposium. Jan 24, 2018 436
Amgen and Allergan's MVASI (Biosimilar Bevacizumab) Approved by European Commission for Treatment of Certain Cancers. Jan 24, 2018 362
Exelixis Presents Phase 1b Results for Cobimetinib plus Atezolizumab in Metastatic Colorectal Cancer at the 2018 ASCO Gastrointestinal Cancers Symposium. Jan 23, 2018 443
United States : European Commission Approves Bristol-Myers Squibbs Yervoy (ipilimumab) for Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma. Jan 23, 2018 288
Opdivo plus Yervoy Shows 55% ORR at 13.4 Months in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer. Jan 22, 2018 328
United States : Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Clinical Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer. Jan 22, 2018 380
Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. Jan 19, 2018 260
Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. Jan 19, 2018 261
Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. Jan 19, 2018 256
Amgen and Allergan's Mvasi for certain cancers approved in Europe. Jan 18, 2018 114
US FDA Approves Lynparza (olaparib) for Germline BRCA-Mutated Metastatic Breast Cancer. Jan 17, 2018 492
CytRx begins dosing in clinical trial for metastatic pancreatic cancer candidate. Jan 17, 2018 141
Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. Jan 17, 2018 207
Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. Jan 17, 2018 209
Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. Jan 17, 2018 209
AstraZeneca wins US FDA expanded approval for Lynparza (olaparib tablets) to treat patients with germline susceptibility gene (BRCA) (HER2)-negative metastatic breast cancer. Jan 15, 2018 347
AstraZeneca wins US FDA expanded approval for Lynparza (olaparib tablets) to treat patients with germline susceptibility gene (BRCA) (HER2)-negative metastatic breast cancer. Jan 15, 2018 343
AstraZeneca and Merck announces FDA approval of Lynparza for metastatic breast cancer. Jan 15, 2018 431
Canada,United States : U.S. FDA Approves LYNPARZA (olaparib) in Germline BRCA-Mutated Metastatic Breast Cancer. Jan 14, 2018 700
Eisai and Merck & Co. Receive Breakthrough Therapy Designation from U.S. FDA for LENVIMA and KEYTRUDA. Jan 9, 2018 1432
Bad cholesterol helps cancer spread. Jan 3, 2018 226
New Biomarker Predicts Metastatic Prostate Cancers. Jan 1, 2018 220
Personalized medicine offers new hope to breast cancer patients. Jan 1, 2018 2236
Plasma hepatic enzymes as biopredictors of type, metastasis, and prognostication of hematological malignancies. Akinlolu, Abdulazeez; Salau, Bamidele; Odewabi, Adesina; Biliaminu, Sikiru; Abdulazeez, Ishola Report Jan 1, 2018 2489
Papillary Carcinoma of Thyroid with Nasal Cavity Metastases: A Case Report. Pourseirafi, Saeid; Shishehgar, Mahmood; Ashraf, Mohammad Javad; Faramarzi, Mohammad Case study Jan 1, 2018 1640
EVALUATION OF HISTOPATHOLOGICAL RISK FACTORS IN ENUCLEATED RETINOBLASTOMA EYES. Acharya, Nibedita; Vasu, Usha Report Jan 1, 2018 2071
Amgen's sBLA for XGEVA (denosumab) to expand the currently approved indication for the prevention of skeletal-related events in patients with bone metastases from solid tumors, has been approved to include multiple myeloma. Jan 1, 2018 217
Occurrence of squamous cell carcinoma in Milchschaf sheep in Uruguay/Ocorrencia do carcinoma de celulas escamosas em ovinos Milchschaf em Uruguai. Garcia, Juan Agustin; Quinteros, Carina; Romero, Agustin; Dutra, Fernando Jan 1, 2018 3023
Transrectal ultrasound-guided prostate biopsies vs. magnetic resonance imaging ultrasound fusion targeted biopsies: Who are the best candidates? Bey, Elsa; Gaget, Olivier; Descotes, Jean-Luc; Franquet, Quentin; Rambeaud, Jean-Jacques; Long, Jean Report Jan 1, 2018 3252
Clinical outcomes of the sequential use of pazopanib followed by everolimus for the treatment of metastatic renal cell carcinoma: A multicentre study in Korea. Kim, Jeong Ho; Lee, Wan; Kim, Tae Nam; Nam, Jong Kil; Kim, Tae Hyo; Lee, Ki Soo Report Jan 1, 2018 3753
Case: Testicular oligometastasis from prostate cancer--Report of rare isolated recurrence after radiotherapy and intermittent androgen-deprivation therapy. Cho, Chan-Kyung J.; Sigurdson, Samantha; Davidson, Christopher M.; Leveridge, Michael; Mahmud, Aamer Clinical report Jan 1, 2018 1729
Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer. Yang, R.F.; Yu, B.; Zhang, R.Q.; Wang, X.H.; Li, C.; Wang, P.; Zhang, Y.; Han, B.; Gao, X.X.; Zhang, Report Jan 1, 2018 5456
Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells. Zhang, S.; Zhang, Y.; Qu, J.; Che, X.; Fan, Y.; Hou, K.; Guo, T.; Deng, G.; Song, N.; Li, C.; Wan, X Report Jan 1, 2018 4188
Odonate Therapeutics Begins Phase 3 Study of Tesetaxel in Patients with Locally Advanced or Metastatic Breast Cancer. Dec 29, 2017 232
Janssen NDA for Apalutamide as Treatment for Non-Metastatic CRPC Garners Priority Review from US FDA. Dec 26, 2017 284
FDA approves Nanobiotix's first Immuno-Oncology trial. Dec 26, 2017 1718
Bad cholesterol can help cancer spread, scientists warn. Dec 23, 2017 207
Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. Dec 22, 2017 282
Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. Dec 22, 2017 278
United States : Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) as Adjuvant Therapy in Patients with Completely Resected Melanoma with Lymph Node Involvement or Metastatic Disease. Dec 21, 2017 303
CHMP Recommends Approval of Yervoy (ipilimumab) for the Treatment of Patients 12 Years and Older with Unresectable or Metastatic Melanoma. Dec 19, 2017 351
CLINICOPATHOLOGICAL STUDY OF TUMOURS OF HYPOPHARYNX. Sadangi, Rajesh Kumar; Misra, Santosh Kumar Report Dec 11, 2017 2028
Eisai: Updated Analysis of Phase Ib/II Study of Eribulin and Pembrolizumab Combination Regimen. Dec 8, 2017 1455
Ibrance (palbociclib) plus Letrozole Improves Progression-Free Survival in ER+, HER2- Metastatic Breast Cancer. Dec 7, 2017 372
Preclinical Data Show Agilvax AX09 Immunotherapy Reduces Tumor Growth and Pulmonary Metastases in Triple Negative Breast Cancer. Dec 7, 2017 252
Fitbit Aids In Understanding Cancer Surgery Recovery Better. Dec 6, 2017 534
CYTOLOGIC PATTERNS OF LUNG CANCER. Prabha, Raj R.L.; Priya, P.V.; Sankar, S. Report Dec 4, 2017 2637
INCIDENCE OF CENTRAL NERVOUS SYSTEM TUMORS IN PATIENTS HOSPITALIZED AT SPLIT UNIVERSITY HOSPITAL CENTRE DURING A TEN-YEAR PERIOD (JANUARY 1, 2004 - DECEMBER 31, 2013). Mizdrak, Maja; Dzamonja, Gordan; Grcic, Petar Filipovic Report Dec 1, 2017 4754
RELAPSE OF PLEOMORPHIC ADENOMA FROM CHILDHOOD TO ADULTHOOD: CASE REPORT. Grabovac, Stjepan; Grabovac, Durdica; Puharic, Zrinka; Dalipi, Vesna Malcic Clinical report Dec 1, 2017 2620
The Effect of Resection Methods on Outcomes in Colorectal Cancers: Does Conversion Matter?/Kolorektal Kanserlerde Rezeksiyon Metodunun Sonuclara Etkisi: Konversiyon Onemli mi? Erdogdu, Umut Eren; Cayci, Haci Murat Report Dec 1, 2017 5032
Systemic Therapy after Radiotherapy Significantly Reduces the Risk of Mortality of Patients with 1-3 Brain Metastases: A Retrospective Study of 250 Patients. Li, Bo; Dai, Zhao-Xia; Chen, Yi-Dong; Liu, Yan-Wei; Liu, Shuai; Gu, Xue-Nan; Qiu, Xiao-Guang Dec 1, 2017 4164
Metastatic Melanoma - Pipeline Review, H2 2015 Now Available at iData Insights. Dec 1, 2017 1841
Germany : Phase III trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone for patients with metastatic castration-resistant prostate cancer unblinded early. Dec 1, 2017 346
Myeloid sarcoma of the thyroid. Goldenberg, Dana; Joshi, Monika; Malysz, Jozef; Claxton, David; Cottrill, Elizabeth E. Report Dec 1, 2017 867
Electrochemotherapy treatment of oral extramedullary plasmacytoma of the tongue: a retrospective study of three dogs/Eletroquimioterapia no tratamento de plasmocitoma extramedular oral na lingua: estudo retrospectivo de tres caes. Cunha, Rubia Monteiro de Castro; Lavalle, Gleidice Eunice; Caires, Carla Emanuela Tertuliano; de Ara Dec 1, 2017 2038
Gene Expression, and Fatigue in Puerto Rican Men during Radiotherapy for Prostate Cancer: an Exploratory Study. Gonzalez, Velda J.; Saligan, Leorey N.; Fridley, Brooke L.; Ortiz-Zuazaga, Humberto; Aaronson, Laure Dec 1, 2017 6201
Cervical Adenocarcinoma: Diagnosis of Human Papillomavirus--Positive and Human Papillomavirus--Negative Tumors. Pirog, Edyta C. Report Dec 1, 2017 9920
AstraZeneca reports acceptance by EMA of Tagrisso submission for 1st-line NSCLC. Nov 28, 2017 236
AstraZeneca reports acceptance by EMA of Tagrisso submission for 1st-line NSCLC. Nov 28, 2017 237
CORRELATION OF COAGULATION MARKERS WITH AXILLARY LYMPH NODE METASTASIS IN CARCINOMA BREAST. Choudhary, Ganpat Singh; Bairwa, Man Singh; Choudhary, Amit; Singodia, Rishi Report Nov 27, 2017 2433
European Commission Extends License for Janssen's Zytiga Plus Prednisone / Prednisolone to Include Earlier Stage Prostate Cancer Patients. Nov 22, 2017 263
Severe Pneumonitis after Nivolumab Treatment Accompanied by Acute Pulmonary Embolism in a Patient with Lung Adenocarcinoma. Liao, Ji-Ping; Nie, Li-Gong; Que, Cheng-Li; Mu, Xiang-Dong Case study Nov 20, 2017 1267
A key to stopping cancer in its tracks. Nov 19, 2017 374
Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. Nov 16, 2017 260
Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. Nov 16, 2017 256
Germany : Novartis reports positive results from Phase III trial of Kisqali (ribociclib) combination therapy in premenopausal women with HR+/HER2- advanced or metastatic breast cancer. Nov 9, 2017 328
Magnetic Resonance Gd-RGD Imaging Study of Hepatocellular Carcinoma with High and Low Metastatic Potential before and after Human Bone Marrow-derived Mesenchymal Stem Cell Intervention. Li, Tian-Ran; Yu, Ming-Hui; Huang, Xiao-Bin; Yang, Zhi-Jie; Lu, Guang-Ming; Li, Yan-Jun Nov 5, 2017 5584
Impact of distant and regional metastasis of non-small-cell lung cancer on endotoxicosis development. Belskaya, Lyudmila V.; Kosenok, Viktor K.; Sarf, Elena A.; Zhuchkov, Sergey A. Nov 1, 2017 5176
Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma. Bukhari, Nedal Report Nov 1, 2017 1532
Neuroendocrine Tumors of the Breast. Rosen, Lauren Elizabeth; Gattuso, Paolo Report Nov 1, 2017 3667
Myxoinflammatory Fibroblastic Sarcoma: Review and Update. Lucas, David R. Report Nov 1, 2017 2505
Metastatic endometrial serous carcinoma to the breast. Lin, Tayson; Lin, David; Zhang, Ziying; Shah, Biren A. Case study Nov 1, 2017 1108
MiR-34-a acts as a suppressor in neuroblastoma progression by targeting CD44. Oct 31, 2017 4267
De novo descending aorta thrombus in a patient with metastatic colorectal cancer: A case report. Oct 31, 2017 1434
Five-year Survival of Newly Diagnosed Stage Four Breast Cancer Has improved. Oct 30, 2017 389
Eagle Pharmaceuticals Receives Tentative FDA Approval for Pemfexy Ready-to-Dilute. Oct 30, 2017 299
A Tuberous Sclerosis Family with TSC1 (c.1030-1G>A) Mutation Found through a Female Presenting as Multiple Ground Glass Nodules in Chest Computed Tomography Incidentally. Zhao, Ting-Ting; Wang, Yong-Sheng; Li, Yan; Ma, Miao; Li, Ai-Mei; Cai, Hou-Rong; Fan, Xiang-Shan; Me Report Oct 20, 2017 1482
OncoSec Releases Data from Recently Completed Studies of ImmunoPulse IL-12 Monotherapy or in Combination with Pembrolizumab in Metastatic Melanoma Patients. Oct 20, 2017 428
Pfizer Study of ALK-Inhibitor Lorlatinib Shows Positive Results Against NSCLC Tumors and Brain Metastases. Oct 18, 2017 409
Protein Biomarker Heterogeneity Observed in Metastatic Breast Cancer Patients. Clinical report Oct 16, 2017 266
US FDA receives new drug application from Janssen Biotech for Apalutamide. Oct 13, 2017 166
United States : Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer. Oct 12, 2017 394
Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. Oct 12, 2017 244
Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. Oct 12, 2017 240
Janssen Submits NDA to US FDA for Apalutamide for Treatment of Non-Metastatic Castration-Resistant Prostate Cancer. Oct 12, 2017 197
OncoSec Begins Enrollment in Clinical Trial of ImmunoPulse IL-12 in Combination with Keytruda (pembrolizumab) in Patients with Unresectable Metastatic Melanoma. Oct 11, 2017 349
Can "Labyrinth" Chip Help Monitor Aggressive Cancer Stem Cells? Oct 2, 2017 743
Can "Labyrinth" Chip Help Monitor Aggressive Cancer Stem Cells?. Oct 2, 2017 749
Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5. Yu, Z.; Cheng, H.; Zhu, H.; Cao, M.; Lu, C.; Bao, S.; Pan, Y.; Li, Y. Report Oct 1, 2017 3818
Rare case of angiosarcoma of the adrenal gland seen with multiple modalities. Varkey, Jastin; Astani, Seyed Amin; Pantelic, Milan; Dalal, Ishani Case study Oct 1, 2017 1283
Serous Tubal Intraepithelial Carcinoma or Not? Metastases to Fallopian Tube Mucosa Can Masquerade as In Situ Lesions. Singh, Reena; Cho, Kathleen R. Report Oct 1, 2017 2171
Chemo causes disease to spread to lungs. Oct 1, 2017 322
Eli Lilly and Company awarded US FDA approval for Verzenio for the treatment of advanced or metastatic breast cancer. Sep 29, 2017 334
Claim for missed cancer diagnosis goes back to jury. Donovan, David Sep 27, 2017 672
Can "Labyrinth" Chip Help Monitor Aggressive Cancer Stem Cells? Nagrath, Sunitha Sep 25, 2017 743
Metastatic Breast Cancer Treatment. Brief article Sep 22, 2017 222
Germany : European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma. Sep 22, 2017 713
Merck KGaA & Pfizer Inc partnership win EC's marketing authorisation for BAVENCIO for metastatic merkel cell carcinoma. Sep 21, 2017 317
United States : Janssen Submits Supplemental New Drug Application to U.S. FDA for ZYTIGA (abiraterone acetate) to Treat Men with Earlier Stages of Metastatic Prostate Cancer. Sep 16, 2017 355

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters